A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin

被引：0
|
作者：
Yi Zheng
Xiaoxuan Tu
Peng Zhao
Weiqin Jiang
Lulu Liu
Zhou Tong
Hangyu Zhang
Cong Yan
Weijia Fang
Weilin Wang
机构：
[1] the First Affiliated Hospital of Zhejiang University,Cancer Biotherapy Centre
[2] the First Affiliated Hospital of Zhejiang University,Department of Hepatobiliary Pancreatic Surgery
来源：
British Journal of Cancer | 2018年 / 119卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 295
页数：4
相关论文
共 50 条
  • [1] A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin
    Zheng, Yi
    Tu, Xiaoxuan
    Zhao, Peng
    Jiang, Weiqin
    Liu, Lulu
    Tong, Zhou
    Zhang, Hangyu
    Yan, Cong
    Fang, Weijia
    Wang, Weilin
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 291 - 295
  • [2] A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin
    He, Shengli
    Shen, Jie
    Sun, Xianjun
    Liu, Luming
    Dong, Jingcheng
    [J]. JOURNAL OF CHEMOTHERAPY, 2014, 26 (04) : 243 - 247
  • [3] Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study
    Larsen, Finn Ole
    Markussen, Alice
    Diness, Laura V.
    Nielsen, Dorte
    [J]. ONCOLOGY, 2018, 94 (01) : 19 - 24
  • [4] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Mizuno, Suguru
    Yamamoto, Keisuke
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Toda, Nobuo
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 708 - 713
  • [5] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Suguru Mizuno
    Keisuke Yamamoto
    Hiroshi Yagioka
    Yoko Yashima
    Kazumichi Kawakubo
    Hirofumi Kogure
    Osamu Togawa
    Saburo Matsubara
    Yukiko Ito
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Nobuo Toda
    Minoru Tada
    Masao Omata
    Kazuhiko Koike
    [J]. Investigational New Drugs, 2012, 30 : 708 - 713
  • [6] A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. CHEMOTHERAPY, 2013, 59 (02): : 106 - 111
  • [8] Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park, Byung Kyu
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Kim, Kyung Sik
    Choi, Jin-Sub
    Lee, Woo Jung
    Song, Si Young
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 999 - 1003
  • [9] A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim, ST
    Park, JO
    Lee, J
    Lee, KT
    Lee, JK
    Choi, SH
    Heo, JS
    Park, YS
    Kang, WK
    Park, K
    [J]. CANCER, 2006, 106 (06) : 1339 - 1346
  • [10] Capecitabine and cisplatin as a second-line chemotherapy for patients with advanced biliary tract cancer
    Shin, Kabsoo
    Lee, In Seok
    Hong, Tae Ho
    Kim, Joori
    Lee, Myung Ah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345